Stock CYC CYCLOPHARM LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Cyclopharm Limited

Equities

CYC

AU000000CYC5

Advanced Medical Equipment & Technology

Market Closed - Australian S.E.
Other stock markets
 02:10:06 2024-07-16 am EDT 		5-day change 1st Jan Change
1.68 AUD +1.20% Intraday chart for Cyclopharm Limited 0.00% -12.73%
May. 27 Cyclopharm Raises AU$20 Million Share Placement for Technegas Commercialization; Shares Down 16% MT
May. 24 Cyclopharm to Raise AU$20 Million via Placement, AU$2 Million via Share Purchase Plan MT

Business Summary

Cyclopharm Limited is an Australia-based radiopharmaceutical company. The Company's principal activity is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its segments include Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The Company uses Technegas technology, which is a structured ultra-fine dispersion of radioactive labelled carbon, produced by using driedTechnetium-99m in a carbon crucible. The Company distributes its products in approximately 65 countries.

Number of employees: 87

Sales per Business

AUD in Million2022Weight2023Weight Delta
Technegas
100.0 %
23 98.5 % 26 100.0 % +15.13%

Sales per region

AUD in Million2022Weight2023Weight Delta
Europe
56.2 %
12 52.4 % 15 56.2 % +21.76%
Asia Pacific
32.9 %
8 33.6 % 9 32.9 % +11.27%
Canada
10.4 %
3 12.7 % 3 10.4 % -7.50%
Other
0.4 %
0 1.3 % 0 0.4 % -60.87%

Managers

Managers TitleAgeSince
James McBrayer CEO
 Chief Executive Officer 58 08-06-02
Mathew Farag COO
 Chief Operating Officer - 16-12-31
Mark Doverty PRN
 Corporate Officer/Principal - 19-09-29
Sally-Ann Cornelius SAM
 Sales & Marketing - 19-09-29

Members of the board

Members of the board TitleAgeSince
Dianne Angus BRD
 Director/Board Member 63 21-08-09
James McBrayer CEO
 Chief Executive Officer 58 08-06-02
David Heaney CHM
 Chairman 79 06-11-19
Kevin Barrow BRD
 Director/Board Member - 22-08-31
Gregory King BRD
 Director/Board Member - 22-09-26
John Wigglesworth BRD
 Director/Board Member - Feb. 18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 94,096,326 59,354,656 ( 63.08 %) 0 63.08 %

Shareholders

NameEquities%Valuation
Anglo Australian Christian & Charitable Fund
12.20 %
13,211,332 12.20 % 15 M $
Regal Funds Management Pty Ltd.
11.09 %
12,002,783 11.09 % 14 M $
Barings Acceptance Ltd.
10.57 %
11,444,962 10.57 % 13 M $
Chemical Overseas Ltd.
8.486 %
9,188,008 8.486 % 10 M $
CVC LIMITED
6.137 %
6,644,758 6.137 % 7 M $
James McBrayer
4.904 %
5,309,580 4.904 % 6 M $
Investors Mutual Ltd.
2.854 %
3,090,000 2.854 % 3 M $
Mathew Farag
1.365 %
1,478,002 1.365 % 2 M $
Phillips River Pty Ltd.
0.9595 %
1,038,914 0.9595 % 1 M $
Lloyds & Casanove Investment Partners
0.9120 %
987,503 0.9120 % 1 M $

Company contact information

Cyclopharm Ltd.

1 The Crescent Unit 4

2208, Kingsgrove

+

http://www.cyclopharm.com
address Cyclopharm Limited(CYC)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Advanced Medical Equipment & Technology
Other Advanced Medical Equipment & Technology

Sales per Business

Sales per region

Ratings for Cyclopharm Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.125 USD
Average target price
2.064 USD
Spread / Average Target
+83.45%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
CYCLOPHARM LIMITED Stock Cyclopharm Limited
-12.73% 125M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+2.62% 208B
DANAHER CORPORATION Stock Danaher Corporation
+6.44% 182B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+29.61% 155B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+34.96% 115B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.85% 66.52B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+17.38% 53.93B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-4.51% 46.26B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-5.77% 38.22B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+3.71% 36.6B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. CYC Stock
  4. Company Cyclopharm Limited